Patent Number
US8609672B2
Date Applied
August 2011
Date Approved
12-17-2013
Agency
United States
Status
Expired - Fee Related
Abstract
The invention provides novel compounds based on piperazinylpyrimidine derivatives to be used as protein kinase inhibitors. The compounds may be useful in treating or preventing different cellular proliferation disorders, such as cancer. The present invention also provides methods of preparing these compounds, and methods of using the same.
Link to Patent
Recommended Citation
Russu, Wade A. and Shallal, Hassan M., "Piperazinylpyrimidine analogues as protein kinase inhibitors" (2013). Pacific Patents. 5.
https://scholarlycommons.pacific.edu/patents/5